Literature DB >> 26465887

Establishing Corneal Cross-Linking With Riboflavin and UV-A in the Mouse Cornea In Vivo: Biomechanical Analysis.

Arthur Hammer1, Sabine Kling2, Marc-Olivier Boldi3, Olivier Richoz1, David Tabibian1, J Bradley Randleman4, Farhad Hafezi5.   

Abstract

PURPOSE: To establish corneal cross-linking (CXL) with riboflavin and UV-A in in the mouse cornea in vivo and to develop tools to measure the biomechanical changes observed.
METHODS: A total of 55 male C57BL/6 wild-type mice (aged 5 weeks) were divided into 14 groups. Standard CXL parameters were adapted to the anatomy of the mouse cornea, and riboflavin concentration (0.1%-0.5%) and fluence series (0.09-5.4 J/cm²) were performed on the assumption of the endothelial damage thresholds. Untreated and riboflavin only corneas were used as controls. Animals were killed at 30 minutes and at 1 month after CXL. Corneas were harvested. Two-dimensional (2D) biomechanical testing was performed using a customized corneal holder in a commercially available stress-strain extensometer/indenter. Both elastic and viscoelastic analyses were performed. Statistical inference was performed using t-tests and specific mathematical models fitted to the experimental stress-strain and stress-relaxation data. Adjusted P values by the method of Benjamini and Hochberg are reported.
RESULTS: For all CXL treatment groups, stress-relaxation showed significant differences (P < 0.0001) after 120 seconds of constant strain application, with cross-linked corneas maintaining a higher stress (441 ± 40 kPa) when compared with controls (337 ± 39 kPa). Stress-strain analysis confirmed these findings but was less sensitive to CXL-induced changes: at 0.5% of strain, cross-linked corneas remained at higher stress (778 ± 111 kPa) when compared with controls (659 ± 121 kPa).
CONCLUSIONS: Cross-linking was induced in the mouse cornea in vivo, and its biomechanical effect successfully measured. This could create opportunities to study molecular pathways of CXL in transgenic mice.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26465887     DOI: 10.1167/iovs.15-17426

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

Review 1.  Insights to proteomics and metabolomics metal chelation in food crops.

Authors:  Osikemekha Anthony Anani; Inobeme Abel; John Ovie Olomukoro; Ikenna Benedict Onyeachu
Journal:  J Proteins Proteom       Date:  2022-06-20

2.  Optical coherence elastography by ambient pressure modulation for high-resolution strain mapping applied to patterned cross-linking.

Authors:  Sabine Kling
Journal:  J R Soc Interface       Date:  2020-01-22       Impact factor: 4.118

3.  High-intensity corneal collagen crosslinking with riboflavin and UVA in rat cornea.

Authors:  Yirui Zhu; Peter S Reinach; Hanlei Zhu; Qiufan Tan; Qinxiang Zheng; Jia Qu; Wei Chen
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

4.  Collagen V insufficiency in a mouse model for Ehlers Danlos-syndrome affects viscoelastic biomechanical properties explaining thin and brittle corneas.

Authors:  Sabine Kling; Emilio A Torres-Netto; Hormoz Abdshahzadeh; Edgar M Espana; Farhad Hafezi
Journal:  Sci Rep       Date:  2021-08-30       Impact factor: 4.379

5.  Corneal Cross-Linking with Riboflavin and UV-A in the Mouse Cornea in Vivo: Morphological, Biochemical, and Physiological Analysis.

Authors:  Sabine Kling; Arthur Hammer; Alain Conti; Farhad Hafezi
Journal:  Transl Vis Sci Technol       Date:  2017-01-30       Impact factor: 3.283

6.  Detecting Mechanical Anisotropy of the Cornea Using Brillouin Microscopy.

Authors:  Joshua N Webb; Hongyuan Zhang; Abhijit Sinha Roy; James Bradley Randleman; Giuliano Scarcelli
Journal:  Transl Vis Sci Technol       Date:  2020-06-24       Impact factor: 3.283

7.  Crosslinking-Induced Corneal Endothelium Dysfunction and Its Protection by Topical Ripasudil Treatment.

Authors:  Xuemei Wang; Yanlin Zhong; Minghui Liang; Zhirong Lin; Huping Wu; Cheng Li
Journal:  Dis Markers       Date:  2022-01-13       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.